The U.S. National Institutes of Health has awarded new funding that will support research education over at least the next 5 years. With Principal Investigators Professors Stephen Avery (University of Pennsylvania) and Saiful Huq (University of Pittsburgh), the grant will train the next generation of leaders in global oncology with online didactic component through out the year complemented by practical training at sites in the USA and globally. The 12 country sites include, Nigeria, Tanzania,  Brazil, Bangladesh, Brazil, Botswana, Uganda, and others serving as premier local regional hubs of excellence.

H.E. Robie Kakonge, Ambassador of The Republic of Uganda to Washington, DC, announced  a pilot initiative to channel diaspora remittances developed with the Global Health Catalyst (GHC) and the Global Cancer Financing Platform (GCF). The announcement was on the sidelines of the 80th session of the UN General Assembly in New York, in an event hosted by the Bloomberg New Economy International Cancer Coalition. As part of the C4 Outreach, The event convened ministers, multilaterals, clinicians and financiers to build a financially sustainable engine to support cancer control. Building on this the GHC has launched GLOHBX, the world’s first global health-financing operating system — integrating AI analytics, blockchain verification, and guarantee-backed capital flows to make health an investable sector.

The 2025 Global Health Catalyst summit at the Massachusetts Institutes of Technology taking place on June 7 2025 focused on expanding the implementation of the C4 powered by AI/VR/Satellite technology and unprecedented collaborations. The event introduced new hologram technology to support C4 education and C4 care initiatives, and collaborating with more community and faith-based organizations, as described in the recent Nature Medicine publication

The rising cancer incidence and mortality in sub-Saharan Africa (SSA) warrants an increased focus on adopting or developing approaches that can significantly increase access to treatment in the region. One such approach recommended by the Lancet Oncology Commission for sub-Saharan Africa is hypofractionated radiotherapy (HFRT), which can substantially increase access to radiotherapy by reducing the overall duration of time (in days) each person spends being treated. The results of the HFRT for prostate cancer were presented at the African Organization for Research and Training in Cancer (AORTIC) conference in Tunisia. These clinical trials have been supported digitally with ongoing remote support including online collaboration meetings every Saturday.